Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers
about
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancerGenomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast CancerMammary Development and Breast Cancer: A Wnt PerspectiveUnderstanding phenotypic variation in rodent models with germline Apc mutationsActivation of the canonical Wnt/β-catenin pathway in ATF3-induced mammary tumorsGenetic mechanisms in Apc-mediated mammary tumorigenesisHypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesismiR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway.Key signaling nodes in mammary gland development and cancer: β-catenin.Association of single nucleotide polymorphisms in Wnt signaling pathway genes with breast cancer in Saudi patients.The influence of one-carbon metabolism on gene promoter methylation in a population-based breast cancer study.Gene-Specific Promoter Methylation Status in Hormone-Receptor-Positive Breast Cancer Associates with Postmenopausal Body Size and Recreational Physical Activity.Assessment of DNA methylation profiling and copy number variation as indications of clonal relationship in ipsilateral and contralateral breast cancers to distinguish recurrent breast cancer from a second primary tumourExploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies.Modification of the association between recreational physical activity and survival after breast cancer by promoter methylation in breast cancer-related genes.Effects of DNA methylation on expression of tumor suppressor genes and proto-oncogene in human colon cancer cell linesAberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients.A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.Polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based studyPrognostic significance of gene-specific promoter hypermethylation in breast cancer patients.Molecular biomarkers for cancer detection in blood and bodily fluids.DNA methylation assessment as a prognostic factor in invasive breast cancer using methylation-specific multiplex ligation dependent probe amplification.Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.More than two decades of Apc modeling in rodentsInteraction between APC and Fen1 during breast carcinogenesis.Epigenetic targeting in breast cancer: therapeutic impact and future direction.ER and PR signaling nodes during mammary gland development.DNA methylation modifies the association between obesity and survival after breast cancer diagnosis.Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotypeEpigenomics and breast cancerDeacetylation by SIRT1 Reprograms Inflammation and CancerComparison of methylation profiling in cancerous and their corresponding normal tissues from korean patients with breast cancer.Mechanisms for reaching the differentiated state: Insights from neural crest-derived melanocytes.Aberrant promoter CpG methylation and its translational applications in breast cancer.Quantitative assessment of the association between APC promoter methylation and breast cancerFunctional redundancy between Apc and Apc2 regulates tissue homeostasis and prevents tumorigenesis in murine mammary epitheliumCpG methylation of APC promoter 1A in sporadic and familial breast cancer patients.Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations.
P2860
Q21260388-0B26226D-CB64-479A-8957-EF8433C44767Q26738987-C9F8E2F9-383E-4A93-B805-5FA1832318BAQ26740086-8873D5DA-78C7-437B-A6A9-2D917681F4E6Q26824920-054CF52C-94AC-43C4-BD62-8507F11121BFQ27437626-E11B6B6B-C7CB-4BF9-96DB-4817511185B0Q33406237-766766CD-2292-401C-BEFB-49B987762A41Q33556583-7D1DD631-B2F6-4519-89CF-28A05845B724Q33739319-02FC6BFF-EC50-486B-BF63-85A59B883152Q34529305-0B9A52F5-A639-4D21-B8C0-0098D7738114Q34613461-0FF05E09-870D-431B-8C41-F02EA2C9F331Q34630473-88A81DAD-F309-40C4-927F-9C455A586AF7Q35623919-13148F84-4BF6-4C90-ADBE-1C45DC7BF2C3Q35633512-A362C415-A0CD-400E-9C83-7C44FCA69725Q35801963-F0FE3905-D2E9-475F-832E-53688D9A2F24Q35824890-C47E7077-12E5-450C-B7F8-7BEE62849C1DQ36091457-65045A3A-A4D5-4128-9AE0-498DEB9BDBAAQ36286909-26B3D8CD-027B-4566-9FE0-1A3AD43C0F06Q36309199-41EA3723-FA39-48C7-B7D0-4CD6202E5635Q36600205-4DAC2358-2DDD-486C-9AAA-375512B442FDQ36603339-98001E05-63DE-47BE-8FDA-5637CA87CECFQ36607318-37169EC9-17BF-487D-98D7-671728D1A871Q36622838-15A0D54D-BDA6-4265-A6B3-65622269F379Q36627755-10CF5470-F1CB-42FB-9A3C-0D36A03664E3Q36768855-562F21B1-B5F8-491C-BCDE-375DFDD15483Q36787353-4BAF9DAB-3FCF-411E-8480-DCD1A2A7637BQ36847248-2981AF8F-45A5-4943-AA63-E4E27344CA47Q36853315-F5612C76-B38D-47A0-A4DD-0332F081D159Q36856318-F00EB987-87CD-4185-BD5A-31A675292F12Q36924384-385F1D3A-186D-47B4-93CA-69333C1587D3Q36961072-26B68E7A-AFAC-4CE9-BBE2-5EBFCE3813E1Q36977572-1947227E-1031-4218-AE8E-1DFA9B486B67Q37078784-009F625B-B2B2-473C-BA70-4451FF9BBC74Q37150502-AAC8AD5D-BBB0-41A1-A7B1-3E1C93005B4CQ37284980-A1CF9A69-A89B-46DC-AED0-44AE52408296Q37303304-A0B8C022-DC78-4C5D-B1D3-47B02C5C3DFDQ37354053-F506DCDE-9B9A-4B35-8C72-E90BB0234AB3Q37437350-A4C68DCB-EE6F-4653-A8CA-F3FDDBCABC41Q37570033-C40AC95D-14DE-4586-A444-9F99AA3E5CD9Q38968012-A850C051-2D0C-477F-88EC-B2806D287926Q38997020-B34E8AE9-A267-4B57-9E6E-769F20FFE0AA
P2860
Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers
@ast
Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers
@en
Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers
@nl
type
label
Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers
@ast
Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers
@en
Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers
@nl
prefLabel
Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers
@ast
Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers
@en
Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers
@nl
P2093
P2860
P3181
P356
P1476
Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers
@en
P2093
M Kashiwaba
T Motoyama
T Tsuchiya
P2860
P2888
P3181
P356
10.1054/BJOC.2001.1853
P407
P577
2001-07-06T00:00:00Z
P5875
P6179
1036821903